百信國際(00574.HK):2023年中期實現純利451.7萬元
格隆匯11月2日丨百信國際(00574.HK)發佈公吿,截至2023年6月30日止六個月,集團錄得總收益人民幣8283.2萬元,較去年同期的人民幣3338.9萬元增加約148.1%。有關增加主要由於隨着2023年年初新型冠狀病毒(COVID-19)疫情得到控制,經濟及整體市場氣氛逐漸改善;及集團於回顧期間獲得10種新醫藥產品的分銷權。公司股權持有人應占溢利人民幣451.7萬元,上年同期虧損人民幣463.5萬元,基本每股溢利人民幣0.31分。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.